Henry Schein Inc

Research Henry Schein Inc (HSIC) on Bullrun: valuation model: 15.2% overvalued, market cap USD 10.21B, P/E 26.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Henry Schein Inc as 15.2% overvalued; latest market cap is USD 10.21B; P/E is 26.1.

Peer valuation comparison

Latest P/E is 26.12x versus a Healthcare sector median of 24.46x (6.8% above).

Latest P/E is 26.12x versus a United States median of 24.87x (5.1% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 13.18BUSD 419.00MUSD 573.00M31.1%3.27USD 156.00MUSD 764.00MUSD 3.25B
FY2024USD 12.67BUSD 398.00MUSD 700.00M31.7%3.05USD 122.00MUSD 650.00MUSD 3.39B
FY2023USD 12.34BUSD 436.00MUSD 353.00M31.3%3.16USD 171.00MUSD 264.00MUSD 3.66B
FY2022USD 12.65BUSD 566.00MUSD 506.00M30.3%3.91USD 117.00MUSD 1.15BUSD 3.45B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 10.21B26.1n/an/a
20252025-12-31USD 8.75B23.1n/an/a
20242024-12-31USD 8.59B22.7n/an/a
20232023-12-29USD 9.84B22.5n/an/a
20222022-12-30USD 10.83B17.4n/an/a
20212021-12-31USD 10.63B17.6n/an/a

About Henry Schein Inc

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.

Related stock research

Other Healthcare stocks

Frequently asked questions

Is Henry Schein Inc overvalued or undervalued?

Bullrun's valuation model currently marks Henry Schein Inc as 15.2% overvalued.

What is Henry Schein Inc's market cap?

Henry Schein Inc's market capitalization is USD 10.21B.

What is Henry Schein Inc's P/E ratio?

Henry Schein Inc's price-to-earnings (P/E) ratio is 26.1.

What does Henry Schein Inc do?

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.